Schertzer JD - Search Results

1

Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness.

Ryall JG, Schertzer JD, Lynch GS. Ryall JG, et al. Among authors: schertzer jd. Biogerontology. 2008 Aug;9(4):213-28. doi: 10.1007/s10522-008-9131-0. Epub 2008 Feb 26. Biogerontology. 2008. PMID: 18299960 Review.

2

Beta2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle.

Schertzer JD, Plant DR, Ryall JG, Beitzel F, Stupka N, Lynch GS. Schertzer JD, et al. Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E526-33. doi: 10.1152/ajpendo.00399.2004. Epub 2004 Oct 12. Am J Physiol Endocrinol Metab. 2005. PMID: 15479951 Free article.

3

Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function.

Schertzer JD, Plant DR, Lynch GS. Schertzer JD, et al. Mol Ther. 2006 Apr;13(4):795-803. doi: 10.1016/j.ymthe.2005.09.019. Epub 2005 Nov 23. Mol Ther. 2006. PMID: 16309967 Free article.

4

Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.

Harcourt LJ, Schertzer JD, Ryall JG, Lynch GS. Harcourt LJ, et al. Among authors: schertzer jd. Neuromuscul Disord. 2007 Jan;17(1):47-55. doi: 10.1016/j.nmd.2006.08.012. Epub 2006 Nov 28. Neuromuscul Disord. 2007. PMID: 17134898

5

Therapeutic approaches for muscle wasting disorders.

Lynch GS, Schertzer JD, Ryall JG. Lynch GS, et al. Among authors: schertzer jd. Pharmacol Ther. 2007 Mar;113(3):461-87. doi: 10.1016/j.pharmthera.2006.11.004. Epub 2006 Dec 8. Pharmacol Ther. 2007. PMID: 17258813 Review.

6

Attenuation of age-related muscle wasting and weakness in rats after formoterol treatment: therapeutic implications for sarcopenia.

Ryall JG, Schertzer JD, Lynch GS. Ryall JG, et al. Among authors: schertzer jd. J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):813-23. doi: 10.1093/gerona/62.8.813. J Gerontol A Biol Sci Med Sci. 2007. PMID: 17702871

7

Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.

Schertzer JD, van der Poel C, Shavlakadze T, Grounds MD, Lynch GS. Schertzer JD, et al. Am J Physiol Cell Physiol. 2008 Jan;294(1):C161-8. doi: 10.1152/ajpcell.00399.2007. Epub 2007 Nov 7. Am J Physiol Cell Physiol. 2008. PMID: 17989207 Free article.

8

Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury.

Ryall JG, Schertzer JD, Alabakis TM, Gehrig SM, Plant DR, Lynch GS. Ryall JG, et al. Among authors: schertzer jd. J Appl Physiol (1985). 2008 Jul;105(1):165-72. doi: 10.1152/japplphysiol.00317.2007. Epub 2008 Apr 24. J Appl Physiol (1985). 2008. PMID: 18436698 Free article.

9

Anabolic agents for improving muscle regeneration and function after injury.

Lynch GS, Schertzer JD, Ryall JG. Lynch GS, et al. Among authors: schertzer jd. Clin Exp Pharmacol Physiol. 2008 Jul;35(7):852-8. doi: 10.1111/j.1440-1681.2008.04955.x. Clin Exp Pharmacol Physiol. 2008. PMID: 18498534 Review.

10

Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage.

Gehrig SM, Ryall JG, Schertzer JD, Lynch GS. Gehrig SM, et al. Among authors: schertzer jd. Exp Physiol. 2008 Nov;93(11):1190-8. doi: 10.1113/expphysiol.2008.042838. Epub 2008 Jun 20. Exp Physiol. 2008. PMID: 18567600 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page